Medicare Drug Savings Act of 2013
Latest action · Jun 3, 2013 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 16, 2013
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medicare Drug Savings Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require drug manufacturers to pay the Secretary of Health and Human Services (HHS) drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary.
Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2011, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan (PDP) sponsor or MedicareAdvantage (MA) organization for such period.
Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals.
Amends SSA title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program.
Cosponsors 33
Members who signed on, in the order they did. Signatures ran from Apr 16, 2013 to Apr 28, 2014; 4 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | George Miller | Original | Apr 16, 2013 |
| D-WA | Jim McDermott | Original | Apr 16, 2013 |
| D-NJ | Robert E. Andrews | Original | Apr 16, 2013 |
| D-MI | Sander M. Levin | Original | Apr 16, 2013 |
| D-IL | Bobby L. Rush | Apr 17, 2013 | |
| D-NY | Charles B. Rangel | Apr 17, 2013 | |
| D-CO | Diana DeGette | Apr 17, 2013 | |
| D-VI | Donna M. Christensen | Apr 17, 2013 | |
| D-IL | Janice D. Schakowsky | Apr 17, 2013 | |
| D-MD | John P. Sarbanes | Apr 17, 2013 | |
| D-FL | Kathy Castor | Apr 17, 2013 | |
| D-MI | John Conyers, Jr. | Apr 23, 2013 | |
| D-FL | Corrine Brown | May 14, 2013 | |
| D-RI | David N. Cicilline | May 14, 2013 | |
| D-NV | Dina Titus | May 16, 2013 | |
| D-CA | Mark Takano | May 16, 2013 | |
| D-CA | Alan S. Lowenthal | May 17, 2013 | |
| D-TX | Beto O'Rourke | May 17, 2013 | |
| D-MD | Donna F. Edwards | May 21, 2013 | |
| D-NH | Carol Shea-Porter | Jun 5, 2013 | |
| D-NH | Ann M. Kuster | Jun 20, 2013 | |
| D-PA | Matt Cartwright | Jul 11, 2013 | |
| D-GU | Madeleine Z. Bordallo | Jul 23, 2013 | |
| D-ME | Michael H. Michaud | Jul 23, 2013 | |
| D-WI | Gwen Moore | Sep 10, 2013 | |
| D-CA | Jackie Speier | Sep 16, 2013 | |
| D-CA | Adam B. Schiff | Sep 17, 2013 | |
| D-WI | Mark Pocan | Sep 18, 2013 | |
| D-CA | Barbara Lee | Sep 27, 2013 | |
| D-NY | Jerrold Nadler | Dec 9, 2013 | |
| D-CA | Jared Huffman | Dec 11, 2013 | |
| D-CA | Gloria Negrete McLeod | Jan 7, 2014 | |
| D-AZ | Raúl M. Grijalva | Apr 28, 2014 |
Withdrew 1 Eliot L. Engel D-NY Apr 23, 2013
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 16, 2013 |
| Health Subcommittee | Referred Apr 19, 2013 | |
| House | Ways and Means Committee | Referred Apr 16, 2013 |
| Health Subcommittee | Referred Jun 3, 2013 |
Actions 4
Everything that happened, newest first.
- Jun 3, 2013Referred to the Subcommittee on Health.
- Apr 19, 2013Referred to the Subcommittee on Health.
- Apr 16, 2013Introduced in House
- Apr 16, 2013Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H2066.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 740 | Medicare Drug Savings Act of 2013 | Identical bill | Apr 16, 2013 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to require drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals under the Medicare prescription drug benefit program.
- Short Titles as Introduced
- Medicare Drug Savings Act of 2013
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 16, 2013Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.